Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.

by Siri Lillegraven, Jeffrey D Greenberg, George W Reed, Katherine Saunders, Jeffrey R Curtis, Leslie Harrold, Marc C Hochberg, Dimitrios A Pappas, Joel M Kremer, Daniel H Solomon
Published 2019-01-01

The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy

by Maria Karolina Jonsson, Aase Haj Hensvold, Monika Hansson, Anna-Birgitte Aga, Joseph Sexton, Linda Mathsson-Alm, Martin Cornillet, Guy Serre, Siri Lillegraven, Bjørg-Tilde Svanes Fevang, Anca Irinel Catrina, Espen Andre Haavardsholm
Published 2018-07-01

MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients

by Fatima Heinicke, Xiangfu Zhong, Siri T. Flåm, Johannes Breidenbach, Magnus Leithaug, Marthe T. Mæhlen, Siri Lillegraven, Anna-Birgitte Aga, Ellen S. Norli, Maria D. Mjaavatten, Espen A. Haavardsholm, Manuela Zucknick, Simon Rayner, Benedicte A. Lie
Published 2021-04-01

Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4+ Memory Than in CD4+ Naïve T Cells

by Kari Guderud, Kari Guderud, Line H. Sunde, Line H. Sunde, Siri T. Flåm, Siri T. Flåm, Marthe T. Mæhlen, Maria D. Mjaavatten, Siri Lillegraven, Anna-Birgitte Aga, Ida M. Evenrød, Ellen S. Norli, Bettina K. Andreassen, Sören Franzenburg, Andre Franke, Espen A. Haavardsholm, Simon Rayner, Kristina Gervin, Kristina Gervin, Benedicte A. Lie, Benedicte A. Lie
Published 2020-02-01